Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?

Safety-tested modified vaccinia virus Ankara (MVA) has been established as a potent vector system for the development of candidate recombinant vaccines. The versatility of the vector system was recently demonstrated by the rapid production of experimental MVA vaccines for immunization against severe...

Descripción completa

Detalles Bibliográficos
Autores principales: Drexler, Ingo, Staib, Caroline, Sutter, Gerd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2004
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127071/
https://www.ncbi.nlm.nih.gov/pubmed/15560976
http://dx.doi.org/10.1016/j.copbio.2004.09.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127071/
https://www.ncbi.nlm.nih.gov/pubmed/15560976
http://dx.doi.org/10.1016/j.copbio.2004.09.001

Ejemplares similares